Author:
Wang Bo,Wang Xuanyi,Wen Yumei,Fu Jing,Wang Hongyang,Ma Zhangmei,Shi Yan,Wang Bin
Publisher
Springer Science and Business Media LLC
Reference84 articles.
1. Gregory, L., Willem, W. O., Laszlo, R., Jianjun, G. & Padmanee, S. et al. Harnessing the power of the immune system to target cancer. Medicine 64, 71–90 (2013).
2. Santoni, M., Conti, A., Andrikou, K., Bittoni, A. & Lanese, A. et al. Risk of pruritus in cancer patients treated with biological therapies: A systematic review and meta-analysis of clinical trials. Crit Rev Oncol Hematol (2015), 10.1016/j.critrevonc.2015.05.007.
3. Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N. & Smith, D. C. et al. Safety, activity and immune correlates of anti-PD-1 antibody in cancer. New Engl J Med 366(26), 2443–2454 (2012).
4. Schulze, H. J., Cribier, B., Requena, L., Reifenberger, J. & Ferrándiz, C. et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe. Brit J Dermatol 152(5), 939–947 (2005).
5. Rosenberg, S. A., Restifo, N. P., Yang, J. C., Morgan, R. A. & Dudley, M. E. Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat Rev Cancer 8(4), 299–308 (2008).
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献